Research graph
References from Management of Antineutrophil Cytoplasmic Antibody–Associated Alveolar Hemorrhage: A Bayesian Reanalysis of the PEXIVAS Trial. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmoa1803537
10.1056/nejmoa1803537 · External reference
Alveolar hemorrhage in antineutrophil cytoplasmic antibody-associated vasculitis: results of an international randomized controlled trial (PEXIVAS)
10.1164/rccm.202308-1426oc · 2024 · External reference
10.2307/2983527
10.2307/2983527 · External reference
10.1161/circoutcomes.117.003563
10.1161/circoutcomes.117.003563 · External reference
10.1016/j.jclinepi.2008.07.006
10.1016/j.jclinepi.2008.07.006 · External reference
10.1016/s0140-6736(24)01295-9
10.1016/s0140-6736(24)01295-9 · External reference
10.1016/j.jclinepi.2006.01.012
10.1016/j.jclinepi.2006.01.012 · External reference
Bayesian analysis in critical care medicine
10.1164/rccm.201910-2019ed · 2020 · External reference
Clinical trials in critical care: can a Bayesian approach enhance clinical and scientific decision making?
10.1016/s2213-2600(20)30471-9 · 2021 · External reference
10.1164/rccm.201905-0968oc
10.1164/rccm.201905-0968oc · External reference
Applied Bayesian methods in the rheumatic diseases
10.1016/j.rdc.2018.01.003 · 2018 · External reference
Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists’ beliefs
10.1093/rheumatology/keaa803 · 2021 · External reference
10.3899/jrheum.110765
10.3899/jrheum.110765 · External reference
10.3899/jrheum.100632
10.3899/jrheum.100632 · External reference
10.3899/jrheum.100665
10.3899/jrheum.100665 · External reference
Amitriptyline to relieve pain in juvenile idiopathic arthritis: a pilot study using Bayesian metaanalysis of multiple N-of-1 clinical trials
2007 · External reference
10.3899/jrheum.110013
10.3899/jrheum.110013 · External reference
10.3899/jrheum.071169
10.3899/jrheum.071169 · External reference
10.1001/jama.2018.14276
10.1001/jama.2018.14276 · External reference
10.1016/j.jclinepi.2004.08.010
10.1016/j.jclinepi.2004.08.010 · External reference
10.1002/0470092602.ch5
10.1002/0470092602.ch5 · External reference
Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: a propensity-matched analysis using a nationwide administrative database
10.1371/journal.pone.0196009 · 2018 · External reference
Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes
10.1002/art.39562 · 2016 · External reference
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis
10.1136/ard-2024-226339 · 2025 · External reference
10.1038/s41584-018-0145-y
10.1038/s41584-018-0145-y · External reference
10.1093/ndt/17.12.2077
10.1093/ndt/17.12.2077 · External reference
PR3-ANCAs predict relapses in ANCA-associated vasculitis patients after rituximab
10.1093/ndt/gfaa066 · 2021 · External reference
10.1681/asn.2007010090
10.1681/asn.2007010090 · External reference
10.1038/ki.2013.131
10.1038/ki.2013.131 · External reference
Is there still a role of plasma exchange in the current management of ANCA-associated vasculitides?
10.1007/s11926-022-01064-8 · 2022 · External reference
Complications of therapeutic plasma exchange: a retrospective, single-center study of 2505 procedures performed in 338 patients over 15 years
10.1111/1744-9987.14173 · 2024 · External reference
10.1002/jca.20143
10.1002/jca.20143 · External reference
10.1038/s43586-020-00002-1
10.1038/s43586-020-00002-1 · External reference
